Editor-in-Chief
Junfei Jin Doctor (Southeast University)
Guilin Medical University Affiliated Hospital, Guilin, Guangxi · China
Editorial leadership for Journal of Spleen And Liver Research ISSN 2578-2371
Research interests
- My Research Interests Are Focused On Signaling Pathways (Sphingolipid
- Toll-Like Receptor
- And Apoptosis )
- Related Disease (Liver Diseases
- Diabetes)
Biography
- 6/2013-present - Professor and Director of Laboratory of Hepatobiliary and Pancreatic Surgery, Affiliated Hospital of Guilin Medical University, People's Republic of China
- 3/2004-6/2013 (not including 9/2006-2/2007)- Postdoctoral Fellow, Staff Scientist, Medical University of South Carolina, Charleston, SC, USA
- 9/2011-5/2013 - Guest Professor, Guilin Medical University, Guilin, Guangxi 541001, China
- 6/2009-6/2012 - Guest Professor, University of South China, Hengyang, Hunan 421001, China
- 8/1998-2/2004 & 9/2006-2/2007 - Teacher (Instructor), Southeast University, Nanjing, P.R.China
- 8/1992-8/1995 – Resident, Jianshi County Renming Hospital of Hubei Province, P.R.China
Selected publications
- AKT and ERK dual inhibitors: The way forward? 2019 cited 206×
- Licorice root extract and magnesium isoglycyrrhizinate protect against triptolide-induced hepatotoxicity via up-regulation of the Nrf2 pathway 2018 cited 48×
- Ceramide kinase-mediated C1P metabolism attenuates acute liver injury by inhibiting the interaction between KEAP1 and NRF2 2024 cited 13×
- CaMKII/proteasome/cytosolic calcium/cathepsin B axis was present in tryspin activation induced by nicardipine 2019 cited 8×
- Anticancer Activity of Platinum (II) Complex with 2-Benzoylpyridine by Induction of DNA Damage, S-Phase Arrest, and Apoptosis 2020 cited 5×
- Integrative transcriptomic and proteomics profiling analyses reveals PLK1 as a target of curcumol in hepatocellular carcinoma cells 2023 cited 2×
Ranked by citation impact (Crossref) where available, newest otherwise · verified via ORCID.
Considering JSLR for your work?
This journal is guided by Junfei Jin (Guilin Medical University Affiliated Hospital, Guilin, Guangxi) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.